SCHEMBL2380211

SCHEMBL2380211

N#CCOC(=O)CCCCc1c[nH]c2ccccc12

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.66
CYP1A2 P05177 2/20 0.66
CYP3A4 P08684 2/20 0.66
CYP2C9 P11712 2/20 0.66
CYP2C19 P33261 2/20 0.66
CYP2D6 P10635 1/20 0.66
ALDH1A1 P00352 6/20 0.63
MAPT P10636 6/20 0.53
MEN1 O00255 6/20 0.53
KMT2A Q03164 6/20 0.53
LMNA P02545 2/20 0.53
NTRK1 P04629 1/20 0.53
KDM4E B2RXH2 1/20 0.53
HPGD P15428 1/20 0.53
TSHR P16473 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2378990 0.99 SMN1; SMN2 (0.65) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL733667 0.91 SMN1; SMN2 (0.60) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL7399266 0.84 SMN1; SMN2 (0.92) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL9153271 0.81 SMN1; SMN2 (0.67) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL9148446 0.81 CYP1A2 (0.70) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL9153580 0.81 SMN1; SMN2 (0.66) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL28850299 0.80 SMN1; SMN2 (0.64) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL9374131 0.80 SMN1; SMN2 (1.00) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL9152556 0.80 CYP1A2 (0.68) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL28863418 0.79 SMN1; SMN2 (0.75) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017630-B2 Cyclohexylacetic acid compounds GRUENENTHAL GMBH (DE) 2011-09-13 US disclosed
US-20070129347-A1 Cyclohexylacetic acid compounds GRUENENTHAL GMBH (DE) 2007-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129347-A1 Cyclohexylacetic acid compounds ACACA, HCAR2, PCCA SMN1; SMN2 3256/4885CYP1A2 147/4885CYP3A4 409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.